Treatment of Pain Associated With Fibromyalgia
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Daiichi Sankyo
Related studies linked through entity extraction aliases.
Multiple Ascending Dose Study of DS-1093 in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Study of Patritumab in Combination With Erlotinib in Subjects With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC). (HER3-Lung)
- Status
- TERMINATED
- Phase
- PHASE3
Single Ascending Dose Study Using DS-1971 to Assess Safety, Tolerability, and Pharmacokinetics in Healthy Participants.
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trial to Improve Treatment With Blood Thinners in Patients With Atrial Fibrillation
- Status
- COMPLETED
- Phase
- NA
Open-label Study of DS-8273a to Assess Its Safety and Tolerability, and Assess Its Pharmacokinetic and Pharmacodynamic Properties in Subjects With Advanced Solid Tumors or Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
Cancer Venous Thromboembolism (VTE)
- Status
- COMPLETED
- Phase
- PHASE3
Edoxaban vs. Warfarin in Subjects Undergoing Cardioversion of Nonvalvular Atrial Fibrillation (NVAF)
- Status
- COMPLETED
- Phase
- PHASE3
DS1040b/Aspirin Drug/Drug Interaction Study
- Status
- COMPLETED
- Phase
- PHASE1
A Two-part Study in Edoxaban-treated Healthy Subjects to Establish a Punch Biopsy Bleeding Model and to Evaluate the Effect of a 4-factor Prothrombin Complex Concentrate on Anticoagulation
- Status
- COMPLETED
- Phase
- PHASE1
(QuANTUM-R): An Open-label Study of Quizartinib Monotherapy vs. Salvage Chemotherapy in Acute Myeloid Leukemia (AML) Subjects Who Are FLT3-ITD Positive
- Status
- COMPLETED
- Phase
- PHASE3
Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of DS-1150b in Healthy Subjects and Subjects With Type-2 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE1
AMG 162 (Denosumab) Phase 3 Study (DESIRABLE Study) in Participants With Rheumatoid Arthritis on Disease-modifying Antirheumatic Drugs (DMARDs) Treatment
- Status
- COMPLETED
- Phase
- NA
Study to Assess Pharmacokinetics, Immunogenicity and Safety/Tolerability of Patritumab (U3-1287)
- Status
- COMPLETED
- Phase
- PHASE1
Randomized, Placebo-controlled, 2 Period, Single-blind, Sequential, Multiple Ascending Dose Study
- Status
- COMPLETED
- Phase
- PHASE1
A Multiple Ascending Dose Study of Milademetan in Subjects With Advanced Solid Tumors or Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
A Two-Part, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DS-7309 in Healthy Volunteers and Subjects With Type 2 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1b Open Label, Dose Escalation Study of PLX3397 in Combination With Vemurafenib in V600-mutated BRAF Melanoma
- Status
- TERMINATED
- Phase
- PHASE1
Edoxaban in Peripheral Arterial Disease
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease (SCD)
- Status
- TERMINATED
- Phase
- PHASE3